Exelixis Statistics
Total Valuation
Exelixis has a market cap or net worth of $9.51 billion. The enterprise value is $8.51 billion.
Market Cap | 9.51B |
Enterprise Value | 8.51B |
Important Dates
The next estimated earnings date is Tuesday, February 4, 2025, after market close.
Earnings Date | Feb 4, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Exelixis has 285.58 million shares outstanding. The number of shares has decreased by -7.23% in one year.
Current Share Class | 285.58M |
Shares Outstanding | 285.58M |
Shares Change (YoY) | -7.23% |
Shares Change (QoQ) | -0.85% |
Owned by Insiders (%) | 1.62% |
Owned by Institutions (%) | 73.92% |
Float | 239.92M |
Valuation Ratios
The trailing PE ratio is 21.51 and the forward PE ratio is 18.04. Exelixis's PEG ratio is 0.54.
PE Ratio | 21.51 |
Forward PE | 18.04 |
PS Ratio | 4.73 |
Forward PS | 4.33 |
PB Ratio | 4.18 |
P/TBV Ratio | 4.30 |
P/FCF Ratio | 21.97 |
P/OCF Ratio | 20.22 |
PEG Ratio | 0.54 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.38, with an EV/FCF ratio of 19.67.
EV / Earnings | 18.23 |
EV / Sales | 4.09 |
EV / EBITDA | 13.38 |
EV / EBIT | 13.99 |
EV / FCF | 19.67 |
Financial Position
The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.09.
Current Ratio | 3.93 |
Quick Ratio | 3.73 |
Debt / Equity | 0.09 |
Debt / EBITDA | 0.28 |
Debt / FCF | 0.45 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 20.20% and return on invested capital (ROIC) is 15.18%.
Return on Equity (ROE) | 20.20% |
Return on Assets (ROA) | 12.81% |
Return on Capital (ROIC) | 15.18% |
Revenue Per Employee | $1.59M |
Profits Per Employee | $356,431 |
Employee Count | 1,310 |
Asset Turnover | 0.70 |
Inventory Turnover | 3.39 |
Taxes
In the past 12 months, Exelixis has paid $132.98 million in taxes.
Income Tax | 132.98M |
Effective Tax Rate | 22.17% |
Stock Price Statistics
The stock price has increased by +39.64% in the last 52 weeks. The beta is 0.52, so Exelixis's price volatility has been lower than the market average.
Beta (5Y) | 0.52 |
52-Week Price Change | +39.64% |
50-Day Moving Average | 33.31 |
200-Day Moving Average | 26.06 |
Relative Strength Index (RSI) | 40.46 |
Average Volume (20 Days) | 2,098,481 |
Short Selling Information
The latest short interest is 8.36 million, so 2.93% of the outstanding shares have been sold short.
Short Interest | 8.36M |
Short Previous Month | 7.90M |
Short % of Shares Out | 2.93% |
Short % of Float | 3.48% |
Short Ratio (days to cover) | 3.32 |
Income Statement
In the last 12 months, Exelixis had revenue of $2.08 billion and earned $466.92 million in profits. Earnings per share was $1.55.
Revenue | 2.08B |
Gross Profit | 2.00B |
Operating Income | 608.28M |
Pretax Income | 450.97M |
Net Income | 466.92M |
EBITDA | 635.96M |
EBIT | 608.28M |
Earnings Per Share (EPS) | $1.55 |
Balance Sheet
The company has $1.19 billion in cash and $194.45 million in debt, giving a net cash position of $994.72 million or $3.48 per share.
Cash & Cash Equivalents | 1.19B |
Total Debt | 194.45M |
Net Cash | 994.72M |
Net Cash Per Share | $3.48 |
Equity (Book Value) | 2.28B |
Book Value Per Share | 7.96 |
Working Capital | 1.16B |
Cash Flow
In the last 12 months, operating cash flow was $470.28 million and capital expenditures -$37.59 million, giving a free cash flow of $432.69 million.
Operating Cash Flow | 470.28M |
Capital Expenditures | -37.59M |
Free Cash Flow | 432.69M |
FCF Per Share | $1.52 |
Margins
Gross margin is 96.25%, with operating and profit margins of 29.22% and 22.43%.
Gross Margin | 96.25% |
Operating Margin | 29.22% |
Pretax Margin | 28.82% |
Profit Margin | 22.43% |
EBITDA Margin | 30.55% |
EBIT Margin | 29.22% |
FCF Margin | 20.79% |
Dividends & Yields
Exelixis does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 7.23% |
Shareholder Yield | 7.23% |
Earnings Yield | 4.91% |
FCF Yield | 4.55% |
Analyst Forecast
The average price target for Exelixis is $32.75, which is -1.62% lower than the current price. The consensus rating is "Buy".
Price Target | $32.75 |
Price Target Difference | -1.62% |
Analyst Consensus | Buy |
Analyst Count | 16 |
Revenue Growth Forecast (5Y) | 9.91% |
EPS Growth Forecast (5Y) | 32.16% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Exelixis has an Altman Z-Score of 7.79 and a Piotroski F-Score of 7.
Altman Z-Score | 7.79 |
Piotroski F-Score | 7 |